How Long Can You Live with Stage 4 Rectal Cancer? 2026 Reference Standards

There's no single fixed survival timeline that applies to everyone with rectal cancer — even patients with stage 4 (distant metastasis) disease may have a chance at curative-intent treatment if the metastatic lesions can be surgically removed. Korea's national 5-year relative survival rate for colorectal cancer is 75.6% (National Cancer Registry Statistics, 2019–2023), but this is a national aggregate figure, not a prediction of any individual's outcome.

Key Summary

• Korea's 5-year relative survival rate for colorectal cancer is 75.6% (National Cancer Registry Statistics 2019–2023, National Cancer Center Korea Central Cancer Registry). The combined 5-year relative survival rate for all cancers during the same period is 73.7%.
• Based on U.S. SEER data, the 5-year relative survival rate for colorectal cancer is 65.4% (SEER 2016–2022). Both figures are nationwide statistics, not results from any specific hospital.
• Even at stage 4 (distant metastasis), colorectal cancer can sometimes be treated with curative intent if the metastatic sites — such as in the liver or lungs — can be surgically removed. This means stage 4 colorectal cancer covers a wider range of situations than stage 4 in many other cancers.
• When metastatic lesions cannot be removed, systemic chemotherapy becomes the main treatment, with targeted agents or immune checkpoint inhibitors added depending on RAS, BRAF, MSI, and HER2 test results. Patients with MSI-High status are known to respond particularly well to immunotherapy.
• Survival rates are population averages. Individual outcomes vary significantly depending on stage, location of metastasis, age, and overall health status.

What Exactly Does Stage 4 Rectal Cancer Mean?

• Stage 4 means the cancer has spread to distant organs such as the liver, lungs, or peritoneum. In the TNM staging system, this corresponds to a positive M (distant metastasis) classification.
• T (depth of bowel wall invasion) and N (number of lymph nodes involved) determine the extent of surgery and whether pre-surgical treatment is needed, while M determines whether systemic treatment is required.
• Because rectal surgery takes place within the narrow confines of the pelvis, cases with deep wall invasion or lymph node involvement typically follow a standard approach of giving radiation therapy and chemotherapy first to shrink the tumor before surgery.

Is Treatment Still Possible with Metastasis?

• Even with liver or lung metastasis, if those sites can be surgically removed, a combination of chemotherapy and metastasectomy may be used with curative intent.
• When the metastases cannot be removed, systemic chemotherapy becomes the main approach. For liver metastases, resection, radiofrequency ablation, or radiation therapy is chosen based on the number, location, and liver function.
• Marker tests such as MSI/MMR, RAS, BRAF, and HER2 are performed in advanced or metastatic colorectal cancer to determine which drugs to use. Patients with MSI-High status are known to respond particularly well to immunotherapy.

What Is the Treatment Sequence?

• Step 1 — Testing: Colonoscopy and biopsy confirm the tumor's location and histologic type, while abdominal/chest CT and pelvic MRI assess the extent of metastasis and invasion.
• Step 2 — Marker testing: Blood CEA, MSI/MMR, RAS, BRAF, and HER2 tests provide the basis for selecting appropriate drugs.
• Step 3 — Treatment planning: Resectability of metastatic sites is assessed, and the need for preoperative chemotherapy and/or radiation therapy is determined.
• Step 4 — Treatment: Metastasectomy or systemic chemotherapy (combined with targeted therapy and/or immunotherapy) is administered.
• Step 5 — Follow-up: Clinical exams, CEA blood tests, and chest/abdominal CT scans are repeated at set intervals to monitor for recurrence.

FAQ — Do the Survival Statistics Reflect a Specific Hospital's Results?

No. The figures of 75.6% and 65.4% come from nationwide statistics — the National Cancer Registry Statistics (Korea, 2019–2023) and SEER (United States, 2016–2022) — not from any specific hospital's treatment outcomes. Under Korean medical law, hospital-specific outcome data cannot be used in advertising, and actual treatment results vary by individual depending on stage and health status.

FAQ — How Severe Are Chemotherapy Side Effects?

Depending on the drug regimen, chemotherapy side effects — including nausea and vomiting, mouth sores, hair loss, fatigue, low white blood cell counts, and numbness in the hands and feet — typically appear during each treatment cycle and then resolve. Nausea and vomiting affect roughly 70–80% of patients, usually starting within 1 to 8 hours after administration and lasting up to a week. Patients should contact their medical team immediately or visit the emergency room if their temperature rises to 38°C or higher (National Cancer Information Center).

Sources and Notes

• This article was written based on the Colorectal Cancer Note (National Cancer Registry Statistics 2019–2023, National Cancer Center Korea; SEER 2016–2022; NCCN Patient Guidelines) and the Principles of Managing Chemotherapy Side Effects Note (National Cancer Information Center, U.S. National Cancer Institute, NCI).
• This content is intended for general medical information purposes only. Diagnosis, treatment methods, and outcomes may vary depending on individual circumstances. Accurate diagnosis and treatment decisions should always be made in consultation with a medical professional.